Albumin Dosing Calculation for 77-kg Patient
For a 77-kg patient receiving 20% albumin (10 g per 50 mL), you need 577.5 mL for the 1.5 g/kg dose and 385 mL for the 1.0 g/kg dose.
Dose Calculations
For 1.5 g/kg dose:
- Total albumin needed: 77 kg × 1.5 g/kg = 115.5 g
- Volume required: 115.5 g ÷ (10 g/50 mL) = 577.5 mL of 20% albumin
For 1.0 g/kg dose:
- Total albumin needed: 77 kg × 1.0 g/kg = 77 g
- Volume required: 77 g ÷ (10 g/50 mL) = 385 mL of 20% albumin
Clinical Context for These Doses
The 1.5 g/kg and 1.0 g/kg dosing regimen is the standard protocol for spontaneous bacterial peritonitis (SBP) in cirrhotic patients, where guidelines recommend 1.5 g/kg on day 1 and 1.0 g/kg on day 3 1, 2. This specific dosing has demonstrated mortality reduction (10% vs 29%) and decreased acute kidney injury (10% vs 33%) in landmark trials 2.
Critical Administration Considerations:
Infusion rate matters significantly: The standard dose (1.5 g/kg day 1.0 g/kg day 3) infused over 6 hours caused symptomatic circulatory overload in 100% of patients in one trial, requiring premature discontinuation 3. Guidelines suggest infusing 20% albumin at no more than 2 mL per minute in hypoproteinemic patients to prevent circulatory embarrassment and pulmonary edema 4.
Volume status assessment is mandatory: Before administering these doses, carefully evaluate for signs of fluid overload, as 20% albumin expands plasma volume by approximately twice the infused volume by drawing interstitial fluid into the vascular space 4, 5. This hyperoncotic effect means your 577.5 mL infusion will expand plasma volume by approximately 1155 mL.
Watch for circulatory overload: Multiple studies report increased pulmonary edema and fluid overload with albumin, particularly at these higher doses 1. The panel guidelines specifically raise concerns about the 1.5/1.0 g/kg dosing protocol and suggest considering lower daily doses over 3 days as an alternative 1.
For patients with cardiovascular compromise, renal impairment, or pre-existing volume overload, consider modifying the dose downward or extending the infusion duration beyond the standard protocols, as the evidence suggests these standard doses may not be universally tolerated 3.